ARTICLE
|
doi:10.20944/preprints202109.0071.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
lysophospholipids; lysophosphatidic acids; cardiovascular diseases; HPLC-MS/MS; rodent models; pulmonary hypertension; chronic heart failure; hypertension
Online: 3 September 2021 (15:19:54 CEST)